Refresh

Fresenius Kabi Oncology Ltd. - Research Center

532545 FKONCO Group (B) BSE data
Back to Company

Results

Statement

More

Quarterly results in brief
(Rs crore)
Dec' 13 Sep' 13 Jun' 13 Mar' 13 Dec' 12

Sales

84.66 96.15 126.87 93.24 205.04

Operating profit

-36.72 -28.88 8.48 11.35 61.31

Interest

9.94 7.32 -4.68 -2.07 -7.73

Gross profit

-40.46 -36.20 14.01 14.24 69.03

EPS (Rs)

-4.02 -2.83 0.30 -0.49 3.06
Quarterly  results in details
Dec' 13 Sep' 13 Jun' 13 Mar' 13 Dec' 12

Other income

6.20 - 0.86 0.82 -

Stock adjustment

-25.72 -7.67 1.15 -34.52 18.83

Raw material

53.88 35.05 35.59 51.55 29.05

Power and fuel

- - - - -

Employee expenses

20.29 20.37 15.21 17.41 17.16

Excise

- - - - -

Admin and selling expenses

- - - - -

Research and development expenses

34.92 12.20 37.84 9.26 47.95

Expenses capitalised

- - - - -

Other expenses

38.01 65.08 28.60 38.19 30.75

Provisions made

- - - - -

Depreciation

8.34 7.53 6.91 6.53 6.69

Taxation

2.38 1.06 2.31 8.66 13.99

Net profit / loss

-63.63 -44.79 4.80 -7.76 48.36

Extra ordinary item

-12.44 - - -6.81 -

Prior year adjustments

- - - - -

Equity capital

15.82 15.82 15.82 15.82 15.82

Equity dividend rate

- - - - -

Agg.of non-prom. shares (Lacs)

131.51 300.63 300.63 300.63 300.63

Agg.of non promotoholding (%)

8.31 19.00 19.00 19.00 19.00

OPM (%)

-43.38 -30.04 6.69 12.18 29.90

GPM (%)

-44.53 -37.64 10.97 15.14 -

NPM (%)

-70.03 -46.59 3.76 -8.25 -
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com